GLAND - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.8
| Stock Code | GLAND | Market Cap | 31,158 Cr. | Current Price | 1,890 ₹ | High / Low | 2,131 ₹ |
| Stock P/E | 26.2 | Book Value | 610 ₹ | Dividend Yield | 0.95 % | ROCE | 15.8 % |
| ROE | 11.6 % | Face Value | 1.00 ₹ | DMA 50 | 1,759 ₹ | DMA 200 | 1,783 ₹ |
| Chg in FII Hold | -0.32 % | Chg in DII Hold | 0.36 % | PAT Qtr | 326 Cr. | PAT Prev Qtr | 302 Cr. |
| RSI | 69.1 | MACD | 43.1 | Volume | 63,396 | Avg Vol 1Wk | 7,57,469 |
| Low price | 1,200 ₹ | High price | 2,131 ₹ | PEG Ratio | -7.65 | Debt to equity | 0.00 |
| 52w Index | 74.1 % | Qtr Profit Var | 10.4 % | EPS | 71.0 ₹ | Industry PE | 29.1 |
📊 GLAND shows moderate fundamentals with decent profitability, zero debt, and steady earnings growth. Technical indicators (RSI 69, MACD positive, price above both 50 & 200 DMA) suggest strong momentum but also indicate the stock is approaching overbought levels. It is a fair candidate for swing trading, though caution is advised due to valuation concerns and reduced institutional participation.
💡 Optimal Entry Price: Around 1,780–1,820 ₹ (near 200 DMA support).
📈 Exit Strategy: If already holding, consider booking profits near 2,050–2,100 ₹ resistance zone, or exit if price falls below 1,750 ₹ (50 DMA support).
Positive ✅
- Debt-to-equity ratio of 0.00 shows no leverage risk.
- Quarterly PAT growth from 302 Cr. to 326 Cr. (+10.4%) indicates earnings stability.
- EPS of 71 ₹ supports long-term profitability.
- Price trading above both 50 DMA (1,759 ₹) and 200 DMA (1,783 ₹), showing bullish trend.
- MACD positive (43.1) confirms upward momentum.
Limitation ⚠️
- ROE (11.6%) and ROCE (15.8%) are moderate compared to sector leaders.
- RSI at 69.1 indicates near overbought territory, limiting upside potential.
- PEG ratio of -7.65 suggests valuation concerns relative to growth.
- Trading volume significantly below 1-week average, showing weaker participation.
- FII holdings declined (-0.32%), signaling reduced foreign investor confidence.
Company Negative News 📉
- No major negative news reported, but declining FII interest is a concern.
Company Positive News 📈
- Consistent quarterly profit growth (+10.4%).
- Strong position in pharmaceutical manufacturing with global exposure.
Industry 🌐
- Industry P/E at 29.1 indicates sector trades at a premium.
- Pharmaceutical sector benefits from steady demand and export opportunities.
Conclusion 📝
GLAND is a moderately strong candidate for swing trading with bullish technicals and stable earnings. Entry near 1,780–1,820 ₹ offers a safer risk-reward setup. Exit around 2,050–2,100 ₹ or below 1,750 ₹ if momentum weakens. While fundamentals are decent, overbought signals and valuation concerns suggest cautious optimism for short-term trades.